Home / Pharmaceutical company intelligence
FRONTIER DEXTROSE LIMITED site mark
Pharmaceutical company intelligence

FRONTIER DEXTROSE products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer - IV infusions · Lahore · Pakistan

Pakistan pharmaceutical manufacturer specializing in intravenous infusions and medical-grade infusion packaging.

FRONTIER DEXTROSE products in Pakistan

FRONTIER DEXTROSE LIMITED has 30 medicine presentations registered in Pakistan under 14 brands, covering 13 generic medicines. Most of its products are in Fluids & supportive care and Anti-infectives. Its brands with the most registered strengths and packs are Sterifluid (Dextrose water, Dextrose), Mini NaCl (Sodium chloride), Sterifluid DS (Dextrose + Sodium chloride) and Sterifluid NS (Sodium chloride). 30 products have an official DRAP price on MedInfoBase. See all 14 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation12 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer - IV infusions
Address
12 Baqir Lane, Canal View Society, Canal Bank, Lahore, Pakistan
Phone
+92 42 35294335-6; +92 42 35964513
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000633 Frontier Dextrose Limited. · Khyber Pakhtunkhwa
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000633 30 linked products · source seen 12 Nov 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx30public portfolio records represented
REG24unique registrations represented
IDX30indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER8registry-verified exact registrations
PKR30current validated price records
G13generic molecules in indexed catalogue
DF3dosage-form groups
TA2therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage67%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixFRONTIER DEXTROSE LIMITEDShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/frontier-dextrose-limitedGenerated 12 Nov 2026Fluids & supportive care26 · 87%Anti-infectives4 · 13%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioFRONTIER DEXTROSE LIMITEDDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/frontier-dextrose-limitedGenerated 12 Nov 202630presentationsInfusion21 · 70%Injection8 · 27%Solution1 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionFRONTIER DEXTROSE LIMITEDCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/frontier-dextrose-limitedGenerated 12 Nov 202620comparable productsBelow peer median4 · 20%Near peer median6 · 30%Above peer median10 · 50%Company median price position+5.1%Lowest-price equivalents5Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsFRONTIER DEXTROSE LIMITEDCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/frontier-dextrose-limitedGenerated 12 Nov 2026Searle IV Solutions (Pvt) Ltd.10 shared77% overlapMedipak Limited9 shared69% overlapUnisa Pharmaceutical Industries Lim…9 shared69% overlapZafa Pharmaceutical Laboratories (P…8 shared62% overlapNeutro Pharma (Pvt.) Ltd.,8 shared62% overlapMS SIZA INTERNATIONAL PVT LTD.8 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Formulation footprint

Dosage forms

Infusion21 products
Injection8 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where FRONTIER DEXTROSE LIMITED is priced against the market

20 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers24Distinct registrations among indexed, published, presentation-validated products only
Verified price observations30
Products with a verified price30
Products with multiple price observations0
Source records with multiple versions30
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation12 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

24 unique registration(s) · 30 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Mini KCL Potassium chloride 74.6 mg Injection 25ml 076882 PKR 22.02 PKR 0.88/mL 🔒 Pharma Pro
Mini KCL Potassium chloride 74.6 mg Injection 20ml 084258 PKR 17.55 PKR 0.88/mL 🔒 Pharma Pro
Mini NaCl Sodium chloride 9 g/100 mL Injection 30ml 076879 PKR 73.87 PKR 2.46/mL No comparator
Mini NaCl Sodium chloride 9 mg Injection 25ml 084253 PKR 22.02 PKR 0.88/mL No comparator
Mini NaCl Sodium chloride 0.9% w/v Injection 50ml 084254 PKR 46.16 PKR 0.92/mL 🔒 Pharma Pro
Mini WFI Water for Injection 5 mL Injection 5ml 076881 PKR 13.42 PKR 2.68/mL 🔒 Pharma Pro
Mini WFI Water for Injection 20 mL Injection 20ml 084257 PKR 21.05 PKR 1.05/mL 🔒 Pharma Pro
Mini WFI 10ml Water for Injection 10 mL Injection 10ml 084256 PKR 22.76 PKR 2.28/mL 🔒 Pharma Pro
Stericipro Ciprofloxacin 200 mg IV infusion 100ml 068348 PKR 184.66 PKR 1.85/mL 🔒 Pharma Pro
Sterifluid Dextrose + Sodium chloride 4.3% + 0.18% IV infusion 500ml 049286 PKR 113.53 PKR 0.23/mL 🔒 Pharma Pro
Sterifluid Dextrose water 5 % IV infusion 1000ml 049818 PKR 161.02 PKR 0.16/mL No comparator
Sterifluid Dextrose water 5% IV infusion 500ml 049818 PKR 133.02 PKR 0.27/mL No comparator
Sterifluid Dextrose water 10 % IV infusion 1000ml 049819 PKR 201.27 PKR 0.20/mL No comparator
Sterifluid Dextrose water 10% IV infusion 500ml 049819 PKR 143.52 PKR 0.29/mL No comparator
Sterifluid Dextrose 25% IV infusion 1000ml 056328 PKR 183.78 PKR 0.18/mL 🔒 Pharma Pro
Sterifluid Dextrose 5 % IV infusion 100ml 056329 PKR 87.52 PKR 0.88/mL 🔒 Pharma Pro
Sterifluid DS Dextrose + Sodium chloride 5% + 0.45% IV infusion 500ml 049285 PKR 133.02 PKR 0.27/mL 🔒 Pharma Pro
Sterifluid DS Dextrose + Sodium chloride 5% + 0.9% IV infusion 500ml 050860 PKR 141.77 PKR 0.28/mL 🔒 Pharma Pro
Sterifluid DS Dextrose + Sodium chloride 5% + 0.9% IV infusion 1000ml 050860 PKR 169.77 PKR 0.17/mL 🔒 Pharma Pro
Sterifluid N/3 Dextrose + Sodium chloride 3.3% + 0.3% IV infusion 500ml 064077 PKR 58.07 PKR 0.12/mL 🔒 Pharma Pro
Sterifluid N/3 Dextrose + Sodium chloride 3.3% + 0.3% IV infusion 1000ml 064077 PKR 70.39 PKR 0.07/mL 🔒 Pharma Pro
Sterifluid NS Sodium chloride 9 g IV infusion 1000ml 051074 PKR 154.02 PKR 0.15/mL No comparator
Sterifluid NS Sodium chloride 0.9% w/v IV infusion 500ml 051074 PKR 122.52 PKR 0.25/mL 🔒 Pharma Pro
Sterifluid NS Sodium chloride 0.9 g IV infusion 100ml 056330 PKR 87.52 PKR 0.88/mL 🔒 Pharma Pro
Sterifluid RL Ringer's lactate solution NaCl 0.60g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.31g/100 mL IV infusion 500ml 052739 PKR 136.52 PKR 0.27/mL No comparator
Sterifluid RL Sodium Lactate 0.31 g IV infusion 1000ml 052739 PKR 169.77 PKR 0.17/mL No comparator
Sterilevo Levofloxacin 500 mg IV infusion 100ml 068345 PKR 1,194.26 PKR 11.94/mL 🔒 Pharma Pro
Sterilyte Sodium chloride + Dextrose + Potassium chloride + Sodium citrate NaCl 1.75g + KCl 0.75g + Na citrate 1.45g + Dextrose 10g/500 mL Solution 500ml 056943 PKR 77.78 PKR 0.16/mL 🔒 Pharma Pro
Sterimet Metronidazole 500 mg IV infusion 100ml 068347 PKR 189.93 PKR 1.90/mL 🔒 Pharma Pro
Sterioflox Ofloxacin 200 mg IV infusion 100ml 068346 PKR 170.61 PKR 1.71/mL No comparator
A to Z

All 14 FRONTIER DEXTROSE brands in Pakistan

  • Mini KCL Potassium chloride · 74.6 mg injection
  • Mini NaCl Sodium chloride · 0.9% w/v injection, 9 g/100 mL injection, 9 mg injection
  • Mini WFI Water for Injection · 20 mL injection, 5 mL injection
  • Mini WFI 10ml Water for Injection · 10 mL injection
  • Stericipro Ciprofloxacin · 200 mg infusion
  • Sterifluid Dextrose water, Dextrose · 10 % infusion, 10% infusion, 25% infusion
  • Sterifluid DS Dextrose + Sodium chloride · 5% + 0.45% infusion, 5% + 0.9% infusion
  • Sterifluid N/3 Dextrose + Sodium chloride · 3.3% + 0.3% infusion
  • Sterifluid NS Sodium chloride · 0.9 g infusion, 0.9% w/v infusion, 9 g infusion
  • Sterifluid RL Sodium Lactate, Ringer's lactate solution · 0.31 g infusion, NaCl 0.60g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.31g/100 mL infusion
  • Sterilevo Levofloxacin · 500 mg infusion
  • Sterilyte Sodium chloride + Dextrose + Potassium chloride + Sodium citrate · NaCl 1.75g + KCl 0.75g + Na citrate 1.45g + Dextrose 10g/500 mL solution
  • Sterimet Metronidazole · 500 mg infusion
  • Sterioflox Ofloxacin · 200 mg infusion
Questions

FRONTIER DEXTROSE: common questions

How many products does FRONTIER DEXTROSE have in Pakistan?

FRONTIER DEXTROSE LIMITED has 30 registered medicine presentations in Pakistan, sold under 14 brands and covering 13 generic medicines.

What are the main brands of FRONTIER DEXTROSE?

By number of registered strengths and packs, its largest brands are Sterifluid (Dextrose water, Dextrose), Mini NaCl (Sodium chloride), Sterifluid DS (Dextrose + Sodium chloride), Sterifluid NS (Sodium chloride) and Mini KCL (Potassium chloride). This is not a sales ranking.

Which therapy areas does FRONTIER DEXTROSE cover?

The most products are in Fluids & supportive care (26) and Anti-infectives (4).

Where can I see FRONTIER DEXTROSE medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). FRONTIER DEXTROSE LIMITED — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 12, 2026, from https://medinfobase.com/company/frontier-dextrose-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9